Report cover image

Human Microbiome Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

Publisher Global Market Insights
Published Jan 08, 2025
Length 102 Pages
SKU # GMI19636280

Description

The global human microbiome market was valued at USD 842.4 million in 2023 and is projected to experience remarkable growth, with a compound annual growth rate (CAGR) of 25.7% from 2024 to 2032. This surge is largely fueled by the growing recognition of the microbiota's essential role in health and disease management.As the pharmaceutical sector increasingly adopts microbiome-based therapies, the market is poised for substantial expansion. The demand for personalized medicine and the therapeutic possibilities associated with microbiome-targeted interventions are significant factors driving this growth. A deeper understanding of how the microbiome influences human health propels research and development in this field, particularly in response to the rising prevalence of chronic illnesses and metabolic disorders.

The human microbiome market is categorized by various anatomical sites, including the digestive tract, lungs, reproductive cavity, skin, and other locations. Among these, the digestive tract segment held the largest share at 31.7% in 2023. The gut microbiome is crucial for digestion, immune function, and overall well-being, making it a primary focus for microbiome-based therapies. Research is increasingly focused on the effects of imbalances in gut microbiota, which are linked to various health issues, including obesity and inflammatory bowel disease (IBD).

The market is also segmented by application into therapeutics and diagnostics. The therapeutics sector accounted for 64.7% of the market share in 2023 and is anticipated to see rapid growth through 2032. As researchers gain insights into the microbiome’s role in numerous diseases, there is a concerted effort to develop therapies that can modulate or restore healthy microbiota. Companies are actively developing microbiome-based treatments focusing on gastrointestinal disorders, metabolic diseases, and immune-related conditions, with many in the pipeline for clinical trials.

North America leads the human microbiome market, achieving a value of USD 261.2 million in 2023, with a projected CAGR of 24.9% through 2032. This dominance can be attributed to major pharmaceutical firms, a robust research infrastructure, and increasing investments in microbiome therapeutics. The region's strong regulatory support for innovation, rising healthcare expenditures, and heightened awareness of personalized medicine positions it for sustained market growth as more microbiome-based therapies gain regulatory approval.

Table of Contents

102 Pages
Chapter 1 Methodology
1.1 Market segmentation
1.2 Market definitions
1.3 Research design
1.4 Market size estimates and calculations
1.4.1 Approach 1: Data mining approach
1.4.2 Approach 2: Investor presentation
1.5 Key trends for market estimates
1.6 Forecast model
1.7 Primary research & validation
1.7.1 Primary sources
1.7.2 Data mining sources
1.7.2.1 Paid sources
1.7.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 360° synopsis, 2021 - 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Site trends
2.1.4 Application trends
2.1.5 Disease trends
2.1.6 Product trends
Chapter 3 Human Microbiome Market Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing burden of lifestyle-related diseases and the growing geriatric population
3.2.1.2 Increasing funding initiatives and government program
3.2.1.3 Increasing demand for precision medicine
3.2.2 Industry pitfalls & challenges
3.2.2.1 Long regulatory pathways and high development costs
3.2.2.2 Ethical and safety concern
3.3.1 By site
3.3.2 By application
3.3.3 By disease
3.3.4 By product
3.4 Regulatory landscape
3.4.1 U.S.
3.4.2 Europe
3.5 Porter's analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.1.1 Archer Daniels Midland Company
4.1.2 Ferring Pharmaceuticals
4.1.3 Seres Therapeutics, Inc.
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Company positioning matrix, 2023
4.5 Strategy dashboard
Chapter 5 Human Microbiome Market, By Site
5.1 Digestive tract
5.2 Lung 56
5.3 Reproductive cavity
5.4 Skin 58
5.5 Other sites
Chapter 6 Human Microbiome Market, By Application
6.1 Therapeutics
6.2 Diagnostics
Chapter 7 Human Microbiome Market, By Disease
7.1 Infectious diseases
7.2 Gastrointestinal diseases
7.3 Endocrine and metabolic diseases
7.4 Cancer
7.5 Central nervous system (CNS) disorder
7.6 Other diseases
Chapter 8 Human Microbiome Market, By Product
8.1 Drugs
8.2 Supplements
8.2.1 Probiotics
8.2.2 Prebiotics
8.2.3 Synbiotics
8.3 Diagnostic tests
8.4 Other products
Chapter 9 Human Microbiome Marke, By Region
9.1 North America
9.2 Europe
9.3 Asia Pacific
9.4 Latin America
9.5 Middle East and Africa
Chapter 10 Company Profile
10.1 Archer Daniels Midland Company
10.1.1 Global overview
10.1.2 Business overview
10.1.3 Financial data
10.1.3.1 Annual sales revenue, 2020-2023 (USD Million)
10.1.4 Product landscape
10.1.5 Strategic outlook
10.1.6 SWOT analysis
10.2 Biohm Technologies
10.2.1 Global overview
10.2.2 Business overview
10.2.3 Financial data
10.2.4 Product landscape
10.2.5 Strategic outlook
10.2.6 SWOT analysis
10.3 Biome Diagnostics GmbH
10.3.1 Global overview
10.3.2 Business overview
10.3.3 Financial data
10.3.4 Product landscape
10.3.5 SWOT analysis
10.4 BiomeBank
10.4.1 Global overview
10.4.2 Business overview
10.4.3 Financial data
10.4.4 Product landscape
10.4.5 SWOT analysis
10.5 Ferring
10.5.1 Global overview
10.5.2 Business overview
10.5.3 Financial data
10.5.3.1 Annual sales revenue, 2020-2023 (USD Million)
10.5.4 Product landscape
10.5.5 Strategic outlook
10.5.6 SWOT analysis
10.6 Pendulum Therapeutics
10.6.1 Global overview
10.6.2 Business overview
10.6.3 Financial data
10.6.4 Product landscape
10.6.5 Strategic outlook
10.6.6 SWOT analysis
10.7 Prescient Metabiomics
10.7.1 Global overview
10.7.2 Business overview
10.7.3 Financial data
10.7.4 Product landscape
10.7.5 Strategic outlook
10.7.6 SWOT analysis
10.8 Seres Therapeutics, Inc.
10.8.1 Global overview
10.8.2 Financial data
10.8.2.1 Annual sales revenue, 2020-2023 (USD Million)
10.8.3 Product landscape
10.8.4 Strategic outlook
10.8.5 SWOT analysis
10.9 The BioArte
10.9.1 Global overview
10.9.2 Business overview
10.9.3 Financial data
10.9.4 Product landscape
10.9.5 SWOT analysis
10.10 Viome Life Sciences, Inc.
10.10.1 Global overview
10.10.2 Business overview
10.10.3 Financial data
10.10.4 Product landscape
10.10.5 SWOT analysis

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us